Investing FibroGen stock rises after roxadustat receives Orphan Drug Designation Dylan D. DavisDecember 15, 2025 FibroGen stock rises after roxadustat receives Orphan Drug Designation Source link
JPMorgan says the time is right to buy this fintech stock that had a poor 2025 After underperforming for the majority of the year, JPMorgan believes that the tide will turn for Toast , which provides…
Private credit executive shares his 2026 outlook Private credit executive shares his 2026 outlook Source link
Factbox-Troop pay, Ukraine and social issues – Congress takes up the 2026 NDAA Factbox-Troop pay, Ukraine and social issues – Congress takes up the 2026 NDAA Source link